Renal cell carcinoma is one of the most malignant neoplasms in the urological field. Most of them die as a result of metastases in clinical course. And this has been true in our experience, both for patients receiving chemotherapy and for those treated by nephrectomy. We present here the difference between cases without metastases over five years (28 cases, group I) and cases with metastase (33 cases, group II), with special reference to the clinical and pathological characteristics of patients with metastases secondary to nephrectomy.
There was no relationship between group I and group II concerning with site, mean age, period from the onset of symptoms and the first symptoms. The rapidity of metastasis seemed to vary with the site of metastasis: The median interval to first lung metastases after nephrectomy was one year and a month, hepatic metastases one year and two months, osseous metastases one year and three months, brain metastases one year and two months and lymph node metastases three years and five months.
The mean weight of nephrected tumor for group I was 396gm and that for group II was 571gm. The mean diameter of the tumor for group I was 5.9cm and that for group II was 7.4cm, but there was no significant difference between group I and group II.
There was no significant relationship between group I and group II concerning with preoperative laboratory findings, i. e., LDH, GOT, GPT, γ-GTP, Al-P, Ca, α
2-globulin, E. S. R. and CRP.
A large percentage of group I patients were diagnosed low stage clinically, and low grade pathologically, compared with group II patients. And even in the low staged patients, most of group II patients were high graded. Therefore, histological grade was a critical factor of metastases concerning with postoperative renal cell carcinoma.
View full abstract